EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular risk goal attainment in the United States rheumatologic population

Kaitlyn Granstaff, Sarah Jiang, Sanjana Nallagatla, Anna Grodzinsky

American Journal of Preventive Cardiology · 2026-08 · 28 · 101611

DOI: 10.1016/j.ajpc.2026.101611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-08. Verfasst von Kaitlyn Granstaff und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri Kansas City School of Medicine, Kansas City, MO, USA. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rheumatologic diseases are independently linked to premature cardiovascular (CV) events. The emerging field of cardio-rheumatology addresses the intersection of inflammation and accelerated atherosclerosis driving excess CV risk. Despite calls to action, data on risk factor optimization, antihyperlipidemic therapy, and comorbidities remain limited. Using the largest US analytic cohort to date, we examined antihyperlipidemic prescription patterns in patients with rheumatologic disease and elevated atherosclerotic cardiovascular disease (ASCVD) risk.

Methods

We analyzed deidentified EPIC Cosmos records (277 million patients, 1,597 hospitals, 17 billion encounters) from 1/2020-1/2025. Adults with any of 11 rheumatologic conditions associated with elevated CV risk-including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis, and systemic sclerosis-were included. We described prevalence of elevated ASCVD risk (=7.5%), prescription rates of antihyperlipidemic therapy and attainment of guideline directed LDL-C 20%, 19.9% were not on antihyperlipidemic therapy (17.3% with myalgias).

Conclusion

In this large US cohort, lipid management and CV risk goal attainment were suboptimal across rheumatologic conditions. These findings underscore the need for multidisciplinary cardio-rheumatology care and implementation strategies to improve outcomes in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

Cardio-rheumatologyPrimary preventionlipid management

Autor:innen und Institutionen

  • University of Missouri Kansas City School of Medicine, Kansas City, MO, USA.
  • Saint Luke's Health System/Saint Luke's Mid America Heart Institute, USA.
  • Saint Luke's Muriel Kauffman Institute for Women's Cardiovascular Research, Kansas City, MO, USA.

Zitieren

APA

Granstaff, K., Jiang, S., Nallagatla, S., & Grodzinsky, A. (2026). Cardiovascular risk goal attainment in the United States rheumatologic population. American Journal of Preventive Cardiology, 28, 101611. https://doi.org/10.1016/j.ajpc.2026.101611

Vancouver

Granstaff K, Jiang S, Nallagatla S, Grodzinsky A. Cardiovascular risk goal attainment in the United States rheumatologic population. American Journal of Preventive Cardiology. 2026;28:101611. doi:10.1016/j.ajpc.2026.101611

BibTeX
@article{Granstaff2026,
  author = {Granstaff, Kaitlyn and Jiang, Sarah and Nallagatla, Sanjana and Grodzinsky, Anna},
  title = {Cardiovascular risk goal attainment in the United States rheumatologic population},
  journal = {American Journal of Preventive Cardiology},
  year = {2026},
  volume = {28},
  pages = {101611},
  doi = {10.1016/j.ajpc.2026.101611}
}
Kostenlos starten →